MiniMed Group Income Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Apr '26 Apr 24, 2026	Apr '25 Apr 25, 2025	Apr '24 Apr 26, 2024	Apr '23 Apr 28, 2023
Revenue	3,102	2,715	2,469	2,245
Revenue Growth	14.25%	9.96%	9.98%	-
Cost of Revenue	1,332	1,187	1,031	929
Gross Profit	1,770	1,528	1,438	1,316
Selling, General & Admin	1,183	1,080	1,051	960
Research & Development	448	436	437	429
Other Operating Expenses	17	-21	3	-12
Operating Expenses	1,648	1,495	1,491	1,377
Operating Income	122	33	-53	-61
Other Non Operating Income (Expenses)	1	-1	-1	-6
EBT Excluding Unusual Items	123	32	-54	-67
Merger & Restructuring Charges	-137	-13	-15	-8
Legal Settlements	-18	-165	-	-
Other Unusual Items	-157	-	-	-
Pretax Income	-189	-146	-69	-75
Income Tax Expense	128	52	38	16
Earnings From Continuing Operations	-317	-198	-107	-91
Minority Interest in Earnings	-16	-15	-5	-5
Net Income	-333	-213	-112	-96
Net Income to Common	-333	-213	-112	-96
Net Income Growth	-	-	-	-
Shares Outstanding (Basic)	257	253	253	-
Shares Outstanding (Diluted)	257	253	253	-
Shares Change	1.50%	-	-	-
EPS (Basic)	-1.30	-0.84	-0.44	-
EPS (Diluted)	-1.30	-0.84	-0.44	-
EPS Growth	-	-	-	-

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Apr '26 Apr 24, 2026	Apr '25 Apr 25, 2025	Apr '24 Apr 26, 2024	Apr '23 Apr 28, 2023
Free Cash Flow	-420	-53	-107	-173
Free Cash Flow Per Share	-1.64	-0.21	-0.42	-
Gross Margin	57.06%	56.28%	58.24%	58.62%
Operating Margin	3.93%	1.21%	-2.15%	-2.72%
Profit Margin	-10.73%	-7.85%	-4.54%	-4.28%
Free Cash Flow Margin	-13.54%	-1.95%	-4.33%	-7.71%
EBITDA	278	176	76	54
EBITDA Margin	8.96%	6.48%	3.08%	2.40%
D&A For EBITDA	156	143	129	115
EBIT	122	33	-53	-61
EBIT Margin	3.93%	1.21%	-2.15%	-2.72%

SEC Filings: 10-K · 10-Q